News
World Temperature-Controlled Pharma Packaging To Hit 945.2mn
In 2022, the global market for pharmaceutical temperature-controlled packaging solutions happened to be valued at USD 578.9 million. It is, in all probabilities, set to reach almost USD 945.2 million by 2030, with a CAGR of 6.30% from 2022...
News
Innovations Enhancing Cold Chain Packaging Solutions In 2024
As per the recent projections, the market when it comes to temperature-controlled packaging solutions is most likely to reach almost $26.2 billion by 2030, thereby showcasing a robust yearly growth rate of more than 11.2%.
It is well to be...
News
To Lower Drug Prices, Biden Administration Targets Patents
As per the anonymous sources cited by Politico as well as STAT News, the Biden administration has confirmed that it happens to have the authority to exercise march-in rights so as to reclaim patents when it comes to certain...
News
Advanced Therapies To Be Driven By Innovation-First Mindset
The Advanced Therapies Treatment Centre- ATTC Network has gone on to release a report that stresses the pressing need when it comes to swift and effective changes in the field so as to enhance patient access to advanced therapies.
The...
News
Sustainable Packaging: The Secret to Cutting Costs in the Pharmaceutical Industry
Discover how sustainable packaging practices can help you reduce environmental impact and significantly cut costs.
Read on to uncover the connection between sustainability and profitability in switching to sustainable pharmaceutical packaging solutions starting today.
Understanding the Cost Implications of Traditional Packaging
Traditional...
News
Aptar Pharma Continues Global Expansion Program with ?Opening of New Mumbai Site
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia.
An inauguration ceremony held on December...
News
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Global contract development and manufacturing organisation (CDMO), Recipharm has announced a collaboration with Oz-UK, a Contract Research Organisation (CRO) and provider of solutions for respiratory R&D, to accelerate the development and manufacture of “green” pressurised metered dose inhalers (pMDIs)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read













